ESGCT Annual Event 2026

cell-line

 

 

Together, we see a way to accelerate breakthroughs that could transform life for one million people living with rare diseases.

Our operating companies partner with you to address scientific challenges and deliver impact at every stage with a broad portfolio of solutions.

Special Event:

From discovery to commercial reality: scaling genomic medicine with confidence

October 26 | 3pm-9pm

 

 

 

Rule line

Agenda

Tuesday, October 27

TimeTypeDescriptionRoom / LocationPresenter
TBDPoster

A new approach for high-resolution full and empty AAV capsid analysis

using a high-throughput method for comprehensive AAAV evaluation on a single CE platform

 

SCIEX

TBDStephen Lock
TBDPoster

A single, ready-to-use kit for fast, comprehensive analysis of both plasmid topological

isoforms and linear sizing on a multi-capillary electrophoresis platform

 

SCIEX

TBDStephen Lock

Wednesday, October 28

TimeTypeDescriptionRoom / LocationPresenter
TBDPoster

Application-driven optimization of tangential flow filtration for extracellular vesicle manufacturing

 

CYTIVA

TBDMarion C
TBDPoster

Design and development of an Integrated and Automatic automatic multi- step

chromatography workflow for AAV purification.

 

CYTIVA

TBDAsa/Hans Blom
TBDPoster

From transient screening to stable production: a modular platform enabling accelerated,

scalable and quality-driven AAV manufacturing

 

CYTIVA

TBDCorinna Bialek; Cristina Alves Totoli e Silva;
Keerthana Srinivasan; Martina Ruby;
Daniel Hilbig; Judith Maas; Tanja Kahlau;
Viktoria Mamontova; Simonas Staras;
Kim Bogenrieder; Oliver Wartmann;
Christian Niehus; Jona Drushku;
Julia Mahlberg; Emmanuelle Cameau;
Robert Whitfield
TBDPoster

Next-generation AAV9 affinity resin for improved yield, speed, and scalability

 

CYTIVA

TBDOla Lind; Asa Hagner McWhirter;
Helena Larkner; Andrea Negro;
Gunther Reichenberger
TBDPoster

A next-generation ionizable lipid LNP platform for efficient in vivo CAR T cell generation
across species through passive and active immune cell targeting strategies

 

CYTIVA

TBDMartin Rabel
TBDPoster

Scalable in vitro transcription using the WAVE 25 bioreactor system and Cytiva enzyme
microreactor accessory

 

CYTIVA

TBDShahin Heshmatifar

Thursday, October 29

TimeTypeDescriptionRoom / LocationPresenter
14.00 - 16.00Scientific Talks

Multiplex Emperirical Off-targete Nomination using UNCOVERseq-pools
as a Community-model gRNA Risk Assessment Tool

 

IDT

TBDAndrea Sanchez-Pena
13.30 - 14.30Scientific Talks

Solid tumors across modalities: Early decisions that shape the path to
patient

 

Cytiva

Hall 3, Level 0Moderator: Emmanulle Cameau,
Scientific Director Viral Vectors,
Cytiva

Panelists:
Niels-Bjarne Woods Ph.D. Associate Professor,
Lund Stem Cell Centre,
Lund University, Sweden

Chantal Lagresle , Senior Research Scientist,
Imagine Institute for
Genetic Diseases, Paris
France

Michael Krohn, Co-CEO & Co-Founder,
Akribion Therapeutics,
Frankfurt Germany
TBDPoster

Accelerating Stable AAV Producer Cell Line Development Through

AI-Driven Decision Intelligence

 

Cytiva

TBDJona Drushku; Michelle Hussong;
Yanis Habtoun; Christian Niehus;
Cristina Alves Totoli e Silva;
Nicolas Hirioguen; Sara Cotineau
TBDPoster

Redefining the Cost Equation for AAV Manufacturing: ELEVECTA™ 2.0

reshapes stable production economics

 

Cytiva

TBDEmmanuelle Cameau; Timothy E. Erlandson;
Michelle Hussong; Ines Do Carmo Goncalves
TBDPoster

Successful technology transfer and scale-up of an established T

flask adherent LVV process to an adherent bioreactor platform

 

Cytiva

TBDKlaudia Kałuża, Holy Cross
Cancer Center, Kielce, Poland
TBDPoster

Synergizing Nanoplasmid vector technology and ELEVECTA™

transient cell line to improve AAV quality

 

Cytiva

TBDEmmanuelle Cameau; Kerem Irfan;
Carla Ruggiero; Tyler Kozisek;
Vincent Dammai
TBDPoster

Towards a universal lipid nanoparticle (LNP) platform for multiplex

engineering of next- generation ex vivo cell therapies

 

Cytiva

TBDMartin Rabel

 

 

Rule line

Want to Learn More on How We Are Driving Insights Into Innovation?

aldevron
Beckman Coulter Life Sciences
Cytiva
idt
SCIEX
Genedata Logo

Integrated DNA Technologies has grown from an oligo manufacturer into a leading genomics provider, partnering with scientists and global health organizations to drive breakthroughs at scale. Guided by a commitment to advancing human health, we enable life-changing innovations from lab to life. IDT is Proud to be part of Danaher, we accelerate the impact of tomorrow’s science.

Beckman logo

Beckman Coulter Life Sciences provides lab instruments, workflow automation, scientific insights, and service support for modern laboratories.